Cost Effectiveness Analysis of Rivaroxaban For Treatment of Deep Vein Thrombosis And Pulmonary Embolism In Greece

Authors :: M Matsagkas
Konstantinos I. Gourgoulianis
G Gourzoulidis
John D. Kakisis
Theodoros P. Vassilakopoulos
Georgia Kourlaba
Nikolaos Maniadakis
George Giannakoulas
D Arzoumanidou
Source :: Value in Health. 19:A554
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: medicine.medical_specialty
Rivaroxaban
business.industry
Health Policy
Deep vein
Public Health, Environmental and Occupational Health
Cost-effectiveness analysis
medicine.disease
Thrombosis
Surgery
Pulmonary embolism
medicine.anatomical_structure
medicine
Radiology
business
medicine.drug

Full Text Access

Tools